A randomized controlled trial by Vrieze et al[47] demonstrated that FMT from lean donors significantly improved insulin sensitivity in individuals with metabolic syndrome, attributed to increased abundance of butyrate-producing bacteria. This evidence concerns the gene INS and metabolic syndrome.